$SKYE
Skye Bioscience, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$1.58
▼-1.55%-$0.025
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateSkye Bioscience, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is SKYE down today? It is at $1.58 (-1.55%), and our scanner flagged it 7 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SKYE spikes, and full due diligence on SKYE — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $SKYE 7 times in the last 30 days. Create a free account to track $SKYE, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on SKYE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SKYE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing4Insider trade (Form 4)Sep 24, 2026 · 4 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
5am Partners Vii, Llc Beneficial Owner (10%) | Sold (automatic/other) | -119K 2.7% of company | sold 11% | 981K | $192K at $1.61 | Sep 23, 26 |
Schwab Andrew J. Director | Sold (automatic/other) | -119K 2.7% of company | sold 11% | 981K | $192K at $1.61 | Sep 23, 26 |
5am Partners Vii, Llc Beneficial Owner (10%) | Sold (automatic/other) | -29K 0.6% of company | sold 86% | 5K | $47K at $1.65 | Sep 22, 26 |
Schwab Andrew J. Director | Sold (automatic/other) | -29K 0.6% of company | sold 86% | 5K | $47K at $1.65 | Sep 22, 26 |
5am Partners Vii, Llc Beneficial Owner (10%) | Sold (automatic/other) | -34K 0.8% of company | sold 2.9% | 1.13M | $65K at $1.91 | Sep 16, 26 |
Schwab Andrew J. Director | Sold (automatic/other) | -34K 0.8% of company | sold 2.9% | 1.13M | $65K at $1.91 | Sep 16, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on SKYE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SKYE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
SKYE last traded at $1.58, down 1.55% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Skye Bioscience, Inc. Common Stock (SKYE) is next expected to report earnings on Monday, November 9, 2026, about 41 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The SKYE Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SKYE 7 times in the last 30 days.
SKYE (Skye Bioscience, Inc. Common Stock) trades on XNAS, with a market cap of about $7M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SKYE for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$SKYE discussion
Sign in to ask a question or join the discussion.